Mostra i principali dati dell'item
Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers
dc.creator | Begas E., Tsioutsiouliti A., Kouvaras E., Haroutounian S.A., Kasiotis K.M., Kouretas D., Asprodini E. | en |
dc.date.accessioned | 2023-01-31T07:37:14Z | |
dc.date.available | 2023-01-31T07:37:14Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.1016/j.fct.2016.12.021 | |
dc.identifier.issn | 02786915 | |
dc.identifier.uri | http://hdl.handle.net/11615/71323 | |
dc.description.abstract | Peppermint leaves are widely used for the symptomatic treatment of digestive disorders. Previous studies have shown significant effects of its natural products on human enzyme activity; however, there is no study available concerning the effects of peppermint tea on metabolizing enzymes in humans. Aim of the present study was to investigate the effect of peppermint tea on CYP1A2, CYP2A6, Xanthine Oxidase (XO), N-acetyltranferase-2 (NAT2) and UDP-glucuronosyltransferases-1A1/1A6 (UGT1A1/1A6) activities in healthy subjects. Four males and five females consumed peppermint tea (2 g of dry leaves/200 mL water, twice daily) for six days. CYP1A2, CYP2A6, XO, NAT2 and UGT1A1/1A6 activities were determined before and at the end of the study period, using the following caffeine and paracetamol metabolic ratios: CYP1A2: 17MX/137MX (saliva) and (AFMU+1MU+1MX)/17MU (urine); CYP2A6: 17MU/(17MU + 17MX), XO: 1MU/(1MU+1MX), NAT2, AFMU/(AFMU+1MU+1MX) and UGT1A1/1A6 glucuronidated/total paracetamol, all determined in urine. NAT2 metabolic ratio was significantly reduced following peppermint consumption (0.15 ± 0.13 vs 0.14 ± 0.13; p < 0.05). CYP1A2 urine and saliva indices were reduced, yet not significantly, following peppermint consumption (urine: 3.17 ± 1.08 vs 2.91 ± 0.76, saliva: 0.56 ± 0.12 vs 0.50 ± 0.12; p > 0.05). Peppermint had no influence on CYP2A6, XO and UGT1A1/1A6 indices. Daily ingestion of peppermint tea may alter pharmacokinetics of clinically administered drugs and promote cancer chemoprevention through NAT2 inhibition. © 2016 Elsevier Ltd | en |
dc.language.iso | en | en |
dc.source | Food and Chemical Toxicology | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008698377&doi=10.1016%2fj.fct.2016.12.021&partnerID=40&md5=8bf88b2df7feece933c16775301664ae | |
dc.subject | 1 methyluric acid | en |
dc.subject | 1 methylxanthine | en |
dc.subject | 1,7 dimethyluric acid | en |
dc.subject | 1,7 methylxanthine | en |
dc.subject | arylamine acetyltransferase | en |
dc.subject | caffeine | en |
dc.subject | cytochrome P450 1A2 | en |
dc.subject | cytochrome P450 2A6 | en |
dc.subject | glucuronosyltransferase 1A1 | en |
dc.subject | glucuronosyltransferase 1A6 | en |
dc.subject | paracetamol | en |
dc.subject | unclassified drug | en |
dc.subject | xanthine oxidase | en |
dc.subject | arylamine acetyltransferase | en |
dc.subject | CYP1A2 protein, human | en |
dc.subject | CYP2A6 protein, human | en |
dc.subject | cytochrome P450 1A2 | en |
dc.subject | cytochrome P450 2A6 | en |
dc.subject | glucuronosyltransferase | en |
dc.subject | NAT2 protein, human | en |
dc.subject | plant extract | en |
dc.subject | tea | en |
dc.subject | xanthine oxidase | en |
dc.subject | adult | en |
dc.subject | Article | en |
dc.subject | cancer prevention | en |
dc.subject | chemical composition | en |
dc.subject | controlled study | en |
dc.subject | drug glucuronidation | en |
dc.subject | electrospray mass spectrometry | en |
dc.subject | enzyme activity | en |
dc.subject | enzyme analysis | en |
dc.subject | enzyme inhibition | en |
dc.subject | female | en |
dc.subject | fluid intake | en |
dc.subject | food analysis | en |
dc.subject | food drug interaction | en |
dc.subject | herbal tea | en |
dc.subject | high performance liquid chromatography | en |
dc.subject | human | en |
dc.subject | human experiment | en |
dc.subject | in vivo study | en |
dc.subject | male | en |
dc.subject | normal human | en |
dc.subject | open study | en |
dc.subject | saliva level | en |
dc.subject | urinalysis | en |
dc.subject | urine level | en |
dc.subject | chemistry | en |
dc.subject | drug effects | en |
dc.subject | gene expression regulation | en |
dc.subject | liquid chromatography | en |
dc.subject | mass spectrometry | en |
dc.subject | Mentha piperita | en |
dc.subject | metabolism | en |
dc.subject | middle aged | en |
dc.subject | tea | en |
dc.subject | young adult | en |
dc.subject | Adult | en |
dc.subject | Arylamine N-Acetyltransferase | en |
dc.subject | Chromatography, Liquid | en |
dc.subject | Cytochrome P-450 CYP1A2 | en |
dc.subject | Cytochrome P-450 CYP2A6 | en |
dc.subject | Female | en |
dc.subject | Gene Expression Regulation, Enzymologic | en |
dc.subject | Glucuronosyltransferase | en |
dc.subject | Healthy Volunteers | en |
dc.subject | Humans | en |
dc.subject | Male | en |
dc.subject | Mass Spectrometry | en |
dc.subject | Mentha piperita | en |
dc.subject | Middle Aged | en |
dc.subject | Plant Extracts | en |
dc.subject | Tea | en |
dc.subject | Xanthine Oxidase | en |
dc.subject | Young Adult | en |
dc.subject | Elsevier Ltd | en |
dc.title | Effects of peppermint tea consumption on the activities of CYP1A2, CYP2A6, Xanthine Oxidase, N-acetyltranferase-2 and UDP-glucuronosyltransferases-1A1/1A6 in healthy volunteers | en |
dc.type | journalArticle | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |